Dermata Therapeutics

-$0.01 (-0.22%) Today
-$0.01 (-0.22%) As of 8:44 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell DRMA and other ETFs, options, and stocks.

About DRMA

Dermata Therapeutics, Inc. is a clinical-stage medical dermatology company that focuses on identifying, developing and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin diseases. Its product pipeline includes DMT310, DMT400, and DMT410.

CEO
Gerald T. Proehl
Employees
—
Headquarters
San Diego, California
Founded
2014

DRMA Key Statistics

Market Cap
37.73M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
383.28K
High Today
$4.53
Low Today
$4.36
Open Price
$4.44
Volume
105.08K
52 Week High
$6.50
52 Week Low
$3.94

DRMA Earnings

-$0.70
-$0.47
-$0.23
$0.00
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 15, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure